Positive psychological experiences in allogeneic hematopoietic stem cell transplantation
Hermioni L. Amonoo(Dana-Farber Cancer Institute), Jeff C. Huffman(Harvard University), Halyna L. Vitagliano(Harvard University), William F. Pirl(Memorial Sloan Kettering Cancer Center), Joseph H. Antin(Dana-Farber Cancer Institute), Carlyn F. Scheu(Massachusetts General Hospital), Rachel Millstein(Harvard University), Lydia Brown(The University of Melbourne)
Cited by 23
Related Papers
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
|Journal of Clinical Oncology|1997|1.3k
Effects of Early Integrated Palliative Care in Patients With Lung and GI Cancer: A Randomized Clinical Trial
|Journal of Clinical Oncology|2017|834
Hepatic Veno-Occlusive Disease following Stem Cell Transplantation: Incidence, Clinical Course, and Outcome
|Biology of Blood and Marrow Transplantation|2009|595
Ipilimumab for Patients with Relapse after Allogeneic Transplantation
|New England Journal of Medicine|2016|595
Contribution of bone marrow–derived endothelial cells to human tumor vasculature
|Nature Medicine|2005|480